ARTICLE

Characterization of Bioactive Sialyl Oligosaccharides Separated from Colostrum of Indonesia Dairy Goat

Epi Taufik1,*https://orcid.org/0000-0003-4617-9037, Irma Isnafia Arief1https://orcid.org/0000-0001-8193-0194, Cahyo Budiman1https://orcid.org/0000-0002-2052-9572, Yusuf Wibisono2https://orcid.org/0000-0001-8534-1696, Alfian Noviyanto3,4https://orcid.org/0000-0002-6371-6765
Author Information & Copyright
1Department of Animal Production and Technology, Faculty of Animal Science, IPB University, Bogor 16680, Indonesia
2Department of Bioprocess Engineering, Brawijaya University, Malang 65145, Indonesia
3Department of Mechanical Engineering, Mercu Buana University, Jakarta 11650, Indonesia
4Nano Center Indonesia, Banten 15314, Indonesia
*Corresponding author: Epi Taufik, Department of Animal Production and Technology, Faculty of Animal Science, IPB University, Bogor 16680, Indonesia, Tel: +62-251-8628379, Fax: +62-251-8628379, E-mail: epitaufik@apps.ipb.ac.id

© Korean Society for Food Science of Animal Resources. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Jan 30, 2022 ; Revised: Mar 22, 2022 ; Accepted: Mar 28, 2022

Published Online: May 01, 2022

Abstract

The bioactive functions of oligosaccharides from human milk have been reported by many studies. Many of oligosaccharides isolated from colostrum and/or milk of dairy animals have been reported to have similar chemical structures with those in human colostrum and/or milk. It has been proved by several studies that the oligosaccharides with similar chemical structure shared common bioactivities. Among domesticated dairy animals, bovine/cattle, caprine/goat, and ovine/sheep are the most commonly used species to isolate oligosaccharides from their colostrum and/or milk. Several studies on the oligosaccharides from goat colostrum and milk have revealed similar properties to that of human milk and possess the highest content of sialyl oligosaccharides (SOS) as compared to other ruminants. Indonesia ranks first in Association of Southeast Asian Nations (ASEAN) for goat milk production. Therefore, goat milk is the second most consumed milk in the country. The most reared dairy goat breed in Indonesia is Etawah Grade. However, oligosaccharides from Indonesia dairy animals including goat, have not been characterized. This is the first study to characterize oligosaccharides from Indonesia dairy animals. The present study was aimed to isolate and characterize oligosaccharides, specifically SOS from the colostrum of Etawah Grade goats by using proton/1H-nuclear magnetic resonance. The SOS successfully characterized in this study were: Neu5Ac(α2-3)Gal(β1-4)Glc (3’-N-acetylneuraminyllactose), Neu5Ac(α2-6)Gal(β1-4)Glc (6’-N-acetylneuraminyllactose), Neu5Gc(α2-3)Gal(β1-4)Glc (3’-N-glycolylneuraminyllactose), Neu5Gc(α2-6)Gal(β1-4)Glc (6’-N-glycolylneuraminyllactose), Neu5Ac(α2-6)Gal(β1-4) GlcNAc (6’-N-acetylneuraminyllactosamine) and Neu5Gc(α2-6)Gal(β1-4)GlcNAc (6’-N-glycolylneuraminyllactosamine). This finding shows that Etawah Grade, as a local dairy goat breed in Indonesia, is having significant potential to be natural source of oligosaccharides that can be utilized in the future food and pharmaceutical industries.

Keywords: oligosaccharides; colostrum; milk; Etawah Grade; dairy goat

Introduction

Carbohydrate percentage ranges from a trace to over 10% with lactose as a predominant component in the colostrum or milk of mammals. Other carbohydrate components are constituted by different type of sugars commonly known as milk oligosaccharides (MOS) (Urashima and Taufik, 2010). Oligosaccharides are sugars which are normally composed of 3 to 15 monosaccharides covalently bound by glycosidic linkages. MOS are mostly composed of a lactose core plus hexoses, deoxyhexoses, N-acetylhexosamines, neuraminic acid and fucose (Sundekilde et al., 2012). Usually, in the eutherian species, lactose is a major component over MOS, while in the monotremes, marsupials and some Carnivore species, MOS predominate over lactose (Urashima and Taufik, 2010; Urashima et al., 2013). Colostrum and mature human milk contain 22−24 and 12−13 g/L of human milk oligosaccharides (hMOS), respectively; this oligosaccharide fraction is the third largest solid component, after lactose and lipid (Newburg and Neubauer, 1995). Almost all MOS are having lactose unit in their reducing end, they are divided into two groups; the neutral ones, which do not contain any charged monosaccharide residues, and the acidic ones, which contain one or more negatively charged residues of sialic acid (Gopal and Gill, 2000).

Lactose is generally recognized as an energy source for the newborns (Urashima et al., 2001), while MOS have been observed to have important roles in the human small intestine, and they also affect significantly on the immune and nervous system developments in neonates (Bode, 2012; Plaza-Díaz et al., 2018). Oligosaccharides may act as epithelial receptors for pathogens, thus acting as a potential protector of mucosal cells (Bode, 2012; Bode and Jantscher-Krenn, 2012; Coppa et al., 2006; Crane et al., 1994; Kunz et al., 2014; Lane et al., 2010). Due to these bioactive functions, MOS are thought to have potential on treating bacterial infections and inflammatory (Daddaoua et al., 2006; Lane et al., 2012; Newburg, 1999; Newburg, 2000; Newburg et al., 2016; Perret et al., 2005; Ruiz-Palacios et al., 2003; Yue et al., 2020; Zopf and Roth, 1996).

Human milk is the gold standard for oligosaccharide structure variability and benefit. However, due to ethical and technical constraints, these compounds of human/breast milk cannot be collected on a large amount to evaluate their biological activities in vitro and in vivo as well as for the purpose of infant formula supplementation (Oliveira et al., 2015). Therefore, the colostrum or milk of dairy animals and their products could be used as alternative sources. Oligosaccharides derived from these sources can be utilized by industry for the development of functional foods in the clinical and infant or even adult nutrition (Sousa et al., 2019a).

Heterogeneity of oligosaccharides was observed among animals. Several studies have been done to characterize MOS from colostrum and milk of dairy animals such as: cows (Albrecht et al., 2014; Barile et al., 2010; Nakamura et al., 2003; Saito et al., 1984; Saito et al., 1987), goats (Albrecht et al., 2014; Chatziioannou et al., 2021; Claps et al., 2014; Claps et al., 2016; Lu et al., 2020; Martín-Ortiz et al., 2016; Martín-Ortiz et al., 2017; Martinez-Ferez et al., 2006a; Martinez-Ferez et al., 2006b; Urashima et al., 1994; Urashima et al., 1997; Viverge et al., 1997), sheeps (Nakamura et al., 1998; Sasaki et al., 2016), camels (Alhaj et al., 2013; Fukuda et al., 2010), and reindeer (Taufik et al., 2014). MOS content is varied in the milk or colostrum of different dairy species. Quantitative studies of goat milk oligosaccharides (gMOS) reported a content ranging from 60 to 350 mg/L in mature milk and from 200 to 650 mg/L in colostrum. These numbers are much lower than in human milk/colostrum but higher than that of other domesticated animals, e.g., cows (bMOS; 30−60 mg/L) and sheeps (sMOS; 20−40 mg/L) (van Leeuwen et al., 2020).

The above-mentioned MOS studies on Capra hircus (goat) milk and colostrum were mostly used for the well-known breed of dairy goat such as Alpine and Saanen, only limited of them using local breed such as Guanzhong and Shandong (China), Garganica and Maltese (Italy) and Murciano-Granadina (Spain). However, no studies on the characterization of MOS from Indonesia dairy animals, including goat have been done so far.

In Indonesia, goat is the second in terms of milk production and consumption after cow milk. There are three dairy goat breeds reared mostly by local farmers, namely: Saanen, Etawah Grade (crossbreed of a local goat with the Etawah breed from India) and Sapera (crossbreed of Saanen from Europe with Etawah Grade). Among those breeds, the most reared breed is Etawah Grade. Indonesia ranks first in the Southeast Asia region (Association of Southeast Asian Nations, ASEAN) for goat milk production. According to the Food and Agriculture Organization (FAO, 2021), in 2019 Indonesia produced 369,584 tons of fresh whole goat milk with a total goat population (dairy and meat type) of 19,096,381 heads in 2020 [Badan Pusat Statistik (BPS), 2021]. This is an abundant and promising alternative source for harvesting MOS from natural resources to be further utilized for the food or pharmaceutical industries. Therefore, the present study investigated for the first time the profile of MOS, especially sialylated or sialyl oligosaccharides (SOS) from Etawah Grade colostrum (EGC).

Materials and Methods

Materials

Colostrum samples were collected from two dairy goat farms (Farms I and II) located in Cijeruk and Leuwiliang sub-districts, Bogor district, West Java province, Indonesia. Colostrum samples from Farms I and II were pooled from three to four heads of Etawah Grade goats, respectively. Both samples were collected within 24 hours post-partum. The samples were then labelled as EGCI and EGCII and immediately stored at −20°C until use. Oligosaccharide reference materials (see Table 1 for abbreviations) 3’-SL and 6’-SL were obtained from Sigma-Aldrich (St. Louis, MO, USA). 3’-Neu5GCL was isolated from Greater Galago milk (Taufik et al., 2012), 6’-NeuGcL was isolated from caprine and ovine colostrum (Nakamura et al., 1998; Urashima et al., 1997), 6’-SLN was isolated from caprine colostrum (Urashima et al., 1997) and 6’-Neu5GCLN was isolated from addax colostrum (Ganzorig et al., 2018).

Table 1. Sialyl oligosaccharides characterized in this study
No. Chemical structures Names Peak/fraction
1. Neu5Ac(α2-3)Gal(β1-4)Glc 3’-N-acetylneuraminyllactose (3’-SL) EGCI 1-1
EGCII 1-3-1
2. Neu5Ac(α2-6)Gal(β1-4)Glc 6’-N-acetylneuraminyllactose (6’-SL) EGCI 1-2
EGCII 1-4-1
3. Neu5Gc(α2-3)Gal(β1-4)Glc 3’-N-glycolylneuraminyllactose (3’-Neu5GcL) EGCII 1-4-2
4. Neu5Gc(α2-6)Gal(β1-4)Glc 6’-N-glycolylneuraminyllactose (6’-Neu5GcL) EGCI 1-3
5. Neu5Ac(α2-6)Gal(β1-4)GlcNAc 6’-N-acetylneuraminyllactosamine (6’-SLN) EGCII 1-3-2
6. Neu5Gc(α2-6)Gal(β1-4)GlcNAc 6’-N-glycolylneuraminyllactosamine (6’-Neu5GcLN) EGCII 1-4-3

EGC, Etawah Grade colostrum.

Download Excel Table
Extraction of carbohydrate fraction from the colostrum

To harvest carbohydrate fraction from colostrum samples, colostrum samples were thawed and dissolved with four volumes of chloroform/methanol (2:1, v/v). The mixture was then centrifuged at 4°C and 4,000×g for 30 min. Only the dissolved component in methanol was collected. Methanol was removed from the component by rotary evaporation, and the residue was dissolved in 5 mL of ion exchange water. The residue was then freeze dried. The lyophilized white powder designated as the carbohydrate fraction. The carbohydrate fractions from dairy goat colostrum from Farms I and II were then named as EGCI and EGCII, respectively.

Extraction and purification of sialyl oligosaccharides (SOS) by gel filtration and high-performance liquid chromatography (HPLC)

The lyophilized carbohydrate fraction of each sample was then dissolved by using 2 mL of ion exchange water. The solution of carbohydrate fraction of each sample was filtered and then applied to gel filtration by using BioGel P-2 (<45 μm, Bio Rad Laboratories, Hercules, CA, USA) column (φ 2.5×100 cm) at a flow rate of 0.25 mL/m. Ion exchange water was used as mobile phase. Fraction collector with 95 installed test tubes was used to collect 5 mL of fraction in every 20 minutes. The aliquots of each fraction were then subjected to phenol-sulfuric acid test (DuBois et al., 1956) at 490 nm for hexose analysis and for sialic acid analysis by the periodate-resorcinol test (Jourdian et al., 1971) at 630 nm. All peak fractions generated from both tests, were pooled and lyophilized. Fig. 1 depicted the carbohydrate fraction profile extracted from EGCI and EGCII samples.

kosfa-42-3-426-g1
Fig. 1. Gel chromatograms of the carbohydrate fraction from two pooled samples of EGC: (a) EGCI and (b) EGCII. Elution from a BioGel P-2 column (φ2.5×100 cm) was with distilled water at a flow rate of 15 mL/h, and of 5.0 mL fractions were collected. Each fraction was monitored by the phenol-sulphuric acid method at 490 nm (solid line) and the periodate-resorcinol method at 630 nm (dotted line). EGC, Etawah Grade colostrum.
Download Original Figure

The components which reacted positively to the periodate-resorcinol method for testing sialic acid (Fig. 1), were separated by high-performance liquid chromatography (HPLC) on a TSK Amide-80HR gel column (4.6×250 mm, pore size 80Å, particle size 5 μm: Tosoh, Tokyo, Japan) using an L-2130 pump (Hitachi, Tokyo, Japan). The HPLC for both components from EGCI and EGCII were performed using mobile phase 80% and 50% (v/v) acetonitrile in 15 mmol/L potassium phosphate buffer (pH 5.2) labelled as buffer A and buffer B, respectively. Elution was done using a linear gradient of acetonitrile from buffer A to buffer B, 80%−50% at 60°C at a flow rate of 1 mL/min. UV detector was used to monitor the eluates by measuring the absorbance at 195 nm. The peak fractions of oligosaccharides (Fig. 2) were collected, concentrated by rotary evaporation, and then subjected to proton or 1H-NMR for analysis to determine their chemical structures.

kosfa-42-3-426-g2
Fig. 2. HPLC chromatogram of (a) EGCI and (b) EGCII separated from two pooled samples of EGC. The high performance liquid chromatography was done using a L-2130 pump (Hitachi) on a TSK gel Amide-80HR column (4.6×250 mm, pore size 80 Å, particle size 5 μm; Tosoh). The HPLC were performed using mobile phase 80% and 50% (v/v) acetonitrile (CH3CN) in 15 mmol/L potassium phosphate buffer (pH 5.2) denoted as buffer A and buffer B, respectively. Elution was done using linear gradient of acetonitrile from buffer A to buffer B with the following condition: buffer A=100%, B=0% at 0 min; A=50%, B=50% at 15 min; and A=0%, B=100% at 80 min at a 60°C and flow rate of 1 mL/min. Peaks were detected by UV absorption at 195 nm. HPLC, high-performance liquid chromatography; EGC, Etawah Grade colostrum.
Download Original Figure
Proton nuclear magnetic resonance (NMR) spectroscopy

All spectra of nuclear magnetic resonance (NMR) were recorded in D2O (99.96 atom D%; Sigma-Aldrich, Milwaukee, WI, USA) at 600 Mhz for proton/1H-NMR with a Varian INOVA 600 spectrometer (Varian, Palo Alto, CA, USA) operated at 293.1 K. Chemical shifts are expressed at the change relative to internal 3-(trimethyl)-1-propane sulfuric acid, sodium salt, but measured by reference to internal acetone (δ=2.225).

Results

Separation of sialyl oligosaccharides (SOS) from Etawah Grade colostrum (EGC)
Gel filtration

Fig. 1 shows the chromatogram of the carbohydrate fractions extracted from EGC of EGCI and EGCII as result of gel filtration by using BioGel P-2. The fraction from each sample was separated into four peaks. However, as the focus of the present study is to characterize SOS, only the first peak or fraction from each sample pooled and labelled as EGCI-1 and EGCII-1, respectively (Fig. 1). Those two fractions were assumed to contain SOS due to their positive reaction with the periodate-resorcinol test.

High-performance liquid chromatography (HPLC)

The components in EGCI-1 and EGCII-1 from EGC separated into several peaks by normal-phase HPLC as shown in Fig. 2. The peaks separated from EGCI-1 were designated as EGCI 1-1, EGCI 1-2 and EGCI 1-3, whereas peaks separated from EGCII-1 were designated as EGCII 1-1, EGCII 1-2, EGCII 1-3, EGCII 1-4, and EGCII 1-5.

Chemical characterization of the oligosaccharides by 1H-NMR spectroscopy
Etawah Grade colostrum (EGC) I
EGCI 1-1.

The proton NMR spectrum [chemical shift (ppm) and coupling constant (Hz) in Table 2] of this oligosaccharide in EGCI 1-1 had anomeric shifts at δ 5.222, 4.663, and 4.530 which were assigned to αGluc, βGluc, and β1-4-linked Gal, while the shifts at 1.800, 2.756, and 2.030 were assigned to H-3 axial and equatorial, and NAc shifts of α2-3-linked Neu5Ac. As these shifts were identical to that of original 3’-Neu5AcLac or 3’-SL, this fraction was therefore characterized to be Neu5Ac(α2-3)Gal(β1-4)Glc.

Table 2. Assignment of 1H- nuclear magnetic resonance chemical shifts of fraction EGCI 1-1, 1-2, and 1-3 separated from EGC (EGCI-1)
Reporter group Residue Chemical shifts, δ (coupling constants, Hz)
EGCI 1-1 EGCI 1-2 EGCI 1-3
H-1 Glc α 5.222 (4.0) 5.225 (3.4) 5.227 (3.4)
Glc β 4.663 (8.0) 4.669 (8.0) 4.671 (8.0)
Galβ4 4.530 (8.0) 4.427 (8.0) 4.431 (7.9)
H-3ax Neu5Ac(α2-3) 1.800 (12.01), −12.02)) - -
Neu5Ac(α2-6) - 1.743 (12.61), −12.02)) -
Neu5Gc(α2-6) - 1.762 (12.61), −12.02))
H-3eq Neu5Ac(α2-3) 2.756 (4.63)) - -
Neu5Ac(α2-6) - 2.711 (4.63)) -
Neu5Gc(α2-6) - - 2.731 (4.63))
NAc Neu5Ac(α2-3) 2.030 - -
Neu5Ac(α2-6) - 2.028 -
NGc Neu5Gc(α2-6) - - 4.118

1) J3ax, 4,

2) J3ax, 3eq,

3) J3eq, 4.

EGC, Etawah Grade colostrum.

Download Excel Table
EGCI 1-2.

The spectrum [chemical shift (ppm) and coupling constant (Hz) in Table 2] of this oligosaccharide in EGCI 1-2 had shifts at δ 5.225, 4.669, and 4.427 arising from the H-1 of αGluc, βGluc, and β1-4-linked Gal, respectively. The spectrum’s major shifts were H-3 axial and equatorial, and NAc shifts at δ 1.743, 2.711, and 2.028, respectively. As these shifts were similar to those of authentic 6’-Neu5AcLac or 6’-SL, the oligosaccharide in this fraction was characterized as Neu5Ac(α2-6)Gal(β1-4)Glc.

EGCI 1-3.

The spectrum [chemical shift (ppm) and coupling constant (Hz) in Table 2] of this oligosaccharide in EGCI 1-3 had H-3 axial and equatorial shifts at δ 1.762 and 2.731, respectively, of a sialic residue, indicating it contains an α2-6 sialyl unit. The spectrum does not contain the NAc shif at δ 2.031 but has a shift at δ 4.118, which is deduced to be due to an NGc group of sialic acid. The shifts at δ 5.227, 4.671 and 4.431 were assigned to the H-1 of αGluc, βGluc, and β1-4-linked Gal, respectively. These shifts are similar to those of the GS-3 fraction from Japanese Saanen colostrum isolated by Urashima et al. (1997), and was therefore characterized as Neu5Gc(α2-6)Gal(β1-4)Glc.

Etawah Grade colostrum (EGC) II
EGCII 1-1.

The 1H-NMR spectrum [chemical shift (ppm) and coupling constant (Hz) in Table 3] of this oligosaccharide in EGCII 1-1 had the characteristic doublet-doublet shift at δ 5.424 and a singlet peak at δ 2.052. As this NMR spectrum pattern was similar to those of authentic GlcNAc-1-P, it was thought that this fraction contained GlcNAc-1-P. However, it was shown that the fraction contained another component, because the spectrum had chemical shift at δ 5.223, 4.666, and 4.452, which arose from the αGluc, βGluc, and β1-4-linked Gal of another saccharide. Therefore, this fraction could not be characterized at this stage.

Table 3. Assignment of 1H- nuclear magnetic resonance chemical shifts of fraction EGCII 1-3 and 1-4 separated from EGC (EGCII-1)
Reporter group Residue Chemical shifts, δ (coupling constants, Hz)
EGCII 1-3-1 EGCII 1-3-2 EGCII 1-4-1 EGCII 1-4-2 EGCII 1-4-3
H-1 Glc α 5.221 (4.0) - 5.224 (3.8) 5.224 (3.8) -
GlcNAc α - 5.196 (2.6) - - 5.199 (2.6)
Glc β 4.663 (8.1) - 4.669 (8.0) 4.664 (8.1) -
GlcNAc β - 4.749 (7.7) - - -
Galβ4 4.531 (7.9) 4.447 (7.9) 4.427 (7.9) 4.535 (7.9) 4.446 (7.9)
- 4.451 (7.8) - - 4.452 (7.9)
H-3ax Neu5Ac(α2-3) 1.799
(12.11), −12.12))
- - - -
Neu5Ac(α2-6) - 1.719
(12.11), −12.32))
1.745
(12.31), −12.22))
- -
Neu5Gc(α2-3) - - - 1.817
(12.01), −12.32))
-
Neu5Gc(α2-6) - - - - 1.745
(12.31), −12.22))
H-3eq Neu5Ac(α2-3) 2.755 (4.43)) - - - -
Neu5Ac(α2-6) - 2.667 (4.63)) 2.712 (4.83)) - -
Neu5Gc(α2-3) - - - 2.774 (4.93)) -
Neu5Gc(α2-6) - - - - 2.686 (4.63))
NAc Neu5Ac(α2-3) 2.027 - - - -
Neu5Ac(α2-6) - 2.028 2.028 - -
GlcNAc - 2.063 - - -
NGc Neu5Gc(α2-3) - - - 4.115 -
Neu5Gc(α2-6) - - - - 4.119

1) J3ax, 4,

2) J3ax, 3eq,

3) J3eq, 4.

EGC, Etawah Grade colostrum.

Download Excel Table
EGCII 1-2.

The 1H-NMR spectrum [chemical shift (ppm) and coupling constant (Hz) in Table 3] had anomeric shifts of αGluc, βGluc, and β1-4-linked Gal at δ 5.223, 4.666, and 4.451, respectively. The chemical shifts of H-3 axial and equatorial, and NAc of α2-6-linked Neu5Ac were detected at δ 1.722, 2.669, and 2.027, respectively. However, the saccharide in this fraction was not characterized at this staged, because these shifts of axial and equatorial H-3 anomer were differed from chemical shifts of Neu5Ac(α2-6)Gal(β1-4)Glc (6’-Neu5AcLac) at δ 1.745 and 2.712.

EGCII 1-3.

Based on the 1H-NMR spectrum signals (Fig. 3), it was concluded that the fraction contained two oligosaccharides. Table 3 shows the assignment of the chemical shifts of the components in peaks for EGCII 1-3 and 1-4. The anomeric shifts at δ 5.221, 4.663, and 4.531 were assigned to αGluc, βGluc, and β1-4-linked Gal, while the shifts at δ 1.799, 2.755, and 2.027 were assigned to H-3 axial and equatorial, and NAc shifts of α2-3-linked Neu5Ac. These shifts were identical to those of original 3’-Neu5AcLac or 3’-SL, this fraction is therefore characterized as Neu5Ac(α2-3)Gal(β1-4)Glc (EGCII 1-3-1). Other anomeric shifts were identified in this spectrum at δ 5.196, 4.749, and 4.551 of αGlcNAc, βGlcNAc, and β1-4-linked Gal, respectively, with H-3 axial and equatorial shifts at δ 1.719 and 2.667, respectively. As the shifts were similar to those of the major anomeric shifts for 6’-Neu5AcLacNAc or 6’-SLN of the GS-1 fraction from Japanese Saanen colostrum isolated by Urashima et al. (1997), this component was characterized as Neu5Ac(α2-6)Gal(β1-4)GlcNAc (EGCII 1-3-2). The spectrum also had an NAc shift of GlcNac at δ 2.063. It was concluded that the amounts of 3’Neu5AcLac and 6’-Neu5AcLacNAc in this fraction were rather similar, as the areas of H-3 equatorial shift of α2-3-linked Neu5Ac and α2-6-linked Neu5Ac were similar to each other.

kosfa-42-3-426-g3
Fig. 3. 1H-nuclear magnetic resonance spectrum of the EGCII-1-3 fraction from high-performance liquid chromatography results (Fig. 2). The spectrum contained 2 structures of sialyl oligosaccharides namely: 3’-Sialyllactose [Neu5Ac(α2-3)Gal(β1-4)Glc] (EGCII 1-3-1) and 6’-Sialyllactosamine [Neu5Ac(α2-6)Gal(β1-4)GlcNAc] (EGCII 1-3-2). The spectrum was obtained in D2O (Sigma-Aldrich) at 600 MHz with a Varian INOVA 600 spectrometer (Varian) operated at 283 K. Chemical shifts are expressed relative to internal 3-(trimethylsilyl)-1-propane sulfuric acid, sodium salt, but were actually measured by reference to internal acetone (δ=2.225). EGC, Etawah Grade colostrum.
Download Original Figure
EGCII 1-4.

Based on the 1H-NMR spectrum [chemical shift (ppm) and coupling constant (Hz) in Table 3], this fraction contained a major component as well as minor component. The anomeric shifts at δ 5.224, 4.669, and 4.427 arose from H-1 of αGluc, βGluc, and β1-4-linked Gal of the major component in the fraction. The spectrum had major shifts of H-3 axial and equatorial and NAc shifts at δ 1.745, 2.712, and 2.030, respectively. Due to similarity of chemical shifts of 6’-Neu5AcLac of the previously isolated GG-1-1-2 fraction from Greater Galago milk (Taufik et al., 2012), the major component of this fraction was characterized to be Neu5Ac(α2-6)Gal(β1-4)Glc (EGCII 1-4-1). The spectrum also had anomeric shifts, which arose from a minor saccharide, of βGluc, and β1-4-linked Gal at δ 4.664 and 4.535, respectively. Chemical shifts of H-3 axial and equatorial and NGc of α2-3-linked Neu5Gc were also identified in this spectrum at δ 1.817, 2.774, and 4.115, respectively. Based on these shifts, the 2nd oligosaccharide was characterized to be Neu5Gc(α2-3)Gal(β1-4)Glc (3’-Neu5GcL, EGCII 1-4-2). In addition, other anomeric shifts had been identified at δ 5.119, 4.446, and 4.452 of αGlcNAc and β1-4-linked Gal with H-3 axial and equatorial and NGc shifts at δ 1.745, 2.686, and 4.119, respectively. Based on these chemical shifts, the third saccharide in this fraction was characterized as Neu5Gc(α2-6)Gal(β1-4)GlcNAc (6’-Neu5GcLN, EGCII 1-4-3). The anomeric shifts of this fraction were similar to those from the AC 2-5-3 fraction of addax colostrum reported by Ganzorig et al. (2018).

EGCII 1-5.

The spectrum of this fraction had no clear and significant anomeric shifts. Therefore, the components in this fraction could not be characterized from1H-NMR at this stage.

Discussion

The major SOS characterized in this EGC were 3’-SL, 6’-SL, 6’-Neu5GcL, and 6’-SLN, while the minors were 3’-Neu5GCL and 6’-Neu5GcLN. Compared with the MOS in bovine colostrum, the ratio of 6’-SLN to 3’-SL in this caprine colostrum was rather high, because there is more 3’-SL than 6’-SLN in bovine colostrum (Nakamura et al., 2003). These findings are in line with the report on gMOS composition by Sousa et al. (2019b).

One of the major SOS in bovine colostrum, namely Neu5Acα2-8Neu5Acα2-3Galβ1-4Glc, was not found in this study. However, it is assumed that this saccharide might be contained in this colostrum as a minor component. If one used a mass spectrum-based technique for structure analysis, this might be detected, too.

All the gMOS characterized in this study have been found in caprine milk and colostrum in previous studies (Albrecht et al., 2014; Chatziioannou et al., 2021; Lu et al., 2020; Urashima et al., 1994; Urashima et al., 1997; van Leeuwen et al., 2020). This is to confirm that different proportions of SOS (Claps et al., 2014; Claps et al., 2016), share a common profile of neutral and acidic/SOS as they belong to the same species of Capra hircus.

Many of the previous studies showed that there are some common structures between gMOS and hMOS. Four out of then neutral (β3’-galactosyllactose, β6’-galactosyllactose, 2’-fucosyllactose, Lacto-N-hexaose) and two out of seven acidic (3’-N-acetylneuraminyllactose/3’-SL and 6’-N-acetylneuraminyllactose/6’-SL) were found in milk of both species. Moreover, the Lacto-N-Biose (LNB) unit—the building block of type I hMOS—has also been identified in gMOS (Kiskini and Difilippo, 2013; Sousa et al., 2019b).

gMOS have a more similar profile to those of hMOS as compared to those in bMOS and sMOS. Therefore, gMOS was considered to be the best natural source of oligosaccharides for infants (Leong et al., 2019; Silanikove et al., 2010; van Leeuwen et al., 2020). Some studies have been proved that oligosaccharides containing sialic acid residues or SOS acted as receptor analogue, playing an important role in brain development, and increasing immunity in infants (Bode et al., 2004; Boehm and Stahl, 2007; Yue et al., 2020).

Another characteristic of gMOS that has been reported by some studies showed that fucosylated and sialylated oligosaccharides were available in higher concentration in goat milk or colostrum than in those from other ruminants (Martinez-Ferez et al., 2006a; Martinez-Ferez et al., 2006b; Meyrand et al., 2013). Up to date, the number of identified oligosaccharides structure from goat was 40, and the quantity was 200 to 650 mg/L in colostrum, and 60 to 350 mg/L in mature milk (van Leeuwen et al., 2020). These levels of gMOS’s quantity were significantly lower than those of hMOS (5−20 g/L) but approximately five times greater than bMOS and about 10 times greater than sMOS (Albrecht et al., 2014; van Leeuwen et al., 2020).

SOS concentration ranges from 1 g/L in colostrum to 90–450 mg/L in human mature milk (Martín-Sosa et al., 2003). In goat mature milk, it ranges from 120 to 190 mg/L (Martinez-Ferez et al., 2006b) and in colostrum from 144 to 328 mg/L (Claps et al., 2014; Claps et al., 2016). Among SOS, two of the most representative in human milk/colostrum, similarly in goat milk/colostrum, were 3’-SL and 6’-SL. The concentration of 3’-SL and 6’-SL in hMOS is 100−200 and 1,140−1,310 mg/L, respectively, whereas in gMOS it was 30−50 and 50−70 mg/L, respectively (Kiskini and Difilippo, 2013).

Recently, Huang et al. (2021) reported that 3’-SL and 6’-SL extracted from hMOS showed the ability to significantly reduce apoptosis, restore proliferation, and relieve inflammation of the intestinal cells of neonatal mice under hypoxia. They also indicated that 3’-SL and 6’-SL provided protection against NEC-induced intestinal damage by deactivation of the TLR4/NF-κB pathway. In this study with EGC, we successfully characterized 3’-SL from fractions EGCI 1-1 and EGCII 1-3-1 and 6’-SL from fractions EGCI 1-2 and EGCII 1-4-1 (Table 1) as two major SOS. Based on the above reports, 3’-SL and 6’-SL isolated from goat milk colostrum are suggested to have similar bioactivity to those isolated from human milk or colostrum as they had exactly similar chemical structures.

Several studies on goat milk-based infant formula in comparison to cow milk-based infant formula have been done to investigate the bioactivity, such as prebiotic and anti-infection properties. Among them are two recent studies reported by Leong et al. (2019) and Urakami et al. (2018). Urakami et al. (2018) assessed the sialyl and neutral oligosaccharides from goat and bovine milk and colostrum for use as ingredients for infants. They concluded that gMOS have more potential as ingredients of infant formula or functional foods due to their potency of adherence inhibition, safety, and the availability. Leong et al. (2019) reported that MOS naturally available in goat milk-based infant formula showed strong prebiotic and anti-pathogen adhesion capability which may deliver gut health benefit to infants.

Conclusion

All of the previously mentioned research data showed that goat milk and colostrum are naturally available sources of human-like oligosaccharides. It is both the structural profile and higher content of MOS in milk and colostrum from goats, as opposed to other domestic dairy animals, that places gMOS in the first ranks of animal-derived oligosaccharides. However, data concerning the variation of gMOS profile depending on diet, lactation stage, season, breed, and number of milking still need to be collected. Potential variations in gMOS composition and concentration could be extremely important for their future use. In this study, we successfully characterized the following oligosaccharides from EGC: Neu5Ac(α2-3)Gal(β1-4)Glc (3’-N-acetylneuraminyllactose), Neu5Ac(α2-6)Gal(β1-4)Glc (6’-N-acetylneuraminyllactose), Neu5Gc(α2-3)Gal(β1-4)Glc (3’-N-glycolylneuraminyllactose), Neu5Gc(α2-6)Gal(β1-4)Glc (6’-N-glycolylneuraminyllactose), Neu5Ac(α2-6)Gal (β1-4)GlcNAc (6’-N-acetylneuraminyllactosamine), and Neu5Gc(α2-6)Gal(β1-4)GlcNAc (6’-N-glycolylneuraminyllactosamine). Therefore, EGC and milk are among the readily available natural sources in Indonesia for extracting bioactive MOS to be used in the food or pharmaceutical industries. Further study to investigate and confirm the array and quantity of neutral and acidic oligosaccharides from colostrum and milk of Etawah Grade, as well as other local dairy goat breeds in Indonesia, is of central importance.

Conflicts of Interest

The authors declare no potential conflicts of interest.

Acknowledgements

The authors would like to acknowledge Ministry of Education, Culture, Research and Technology for funding this study under world class research scheme through IPB University grant No. 09/E1/KPT/2021 and contract No. 077/E4.1/AK. 04.PT/2021.

Author Contributions

Conceptualization: Taufik E. Data curation: Taufik E, Budiman C. Formal analysis: Taufik E, Budiman C. Methodology: Taufik E, Budiman C. Software: Taufik E. Validation: Taufik E. Investigation: Budiman C, Arief II, Wibisono Y, Noviyanto A. Writing - original draft: Taufik E. Writing - review & editing: Taufik E, Arief II, Budiman C, Wibisono Y, Noviyanto A.

Ethics Approval

This article does not require IRB/IACUC approval because there are no human and animal participants.

References

1.

Albrecht S, Lane JA, Mariño K, Al Busadah KA, Carrington SD, Hickey RM, Rudd PM. 2014; A comparative study of free oligosaccharides in the milk of domestic animals. Br J Nutr. 111:1313-1328

2.

Alhaj OA, Taufik E, Handa Y, Fukuda K, Saito T, Urashima T. 2013; Chemical characterisation of oligosaccharides in commercially pasteurised dromedary camel (Camelus dromedarius) milk. Int Dairy J. 28:70-75

3.

Badan Pusat Statistik [BPS]. 2021 Populasi Kambing menurut Provinsi (Ekor), 2019–2021. Available fromhttps://www.bps.go.id/indicator/24/472/1/populasi-kambing-menurut-provinsi.htmlAccessed at Nov 19, 2021

4.

Barile D, Marotta M, Chu C, Mehra R, Grimm R, Lebrilla CB, German JB. 2010; Neutral and acidic oligosaccharides in Holstein-Friesian colostrum during the first 3 days of lactation measured by high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry. J Dairy Sci. 93:3940-3949

5.

Bode L. 2012; Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology. 22:1147-1162

6.

Bode L, Jantscher-Krenn E. 2012; Structure-function relationships of human milk oligosaccharides. Adv Nutr. 3:S383-S391

7.

Bode L, Kunz C, Muhly-Reinholz M, Mayer K, Seeger W, Rudloff S. 2004; Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides. Thromb Haemost. 92:1402-1410

8.

Boehm G, Stahl B. 2007; Oligosaccharides from milk. J Nutr. 137(Suppl 2):S847-S849

9.

Chatziioannou AC, Benjamins E, Pellis L, Haandrikman A, Dijkhuizen L, van Leeuwen SS. 2021; Extraction and quantitative analysis of goat milk oligosaccharides: Composition, variation, associations, and 2’-FL variability. J Agric Food Chem. 69:7851-7862

10.

Claps S, Di Napoli MA, Caputo AR, Rufrano D, Sepe L, Di Trana A. 2016; Factor affecting the 3’ sialyllactose, 6’ sialyllactose and disialyllactose content in caprine colostrum and milk: Breed and parity. Small Rumin Res. 134:8-13

11.

Claps S, Di Napoli MA, Sepe L, Caputo AR, Rufrano D, Di Trana A, Annicchiarico G, Fedele V. 2014; Sialyloligosaccharides content in colostrum and milk of two goat breeds. Small Rumin Res. 121:116-119

12.

Coppa GV, Zampini L, Galeazzi T, Facinelli B, Ferrante L, Capretti R, Orazio G. 2006; Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res. 59:377-382

13.

Crane JK, Azar SS, Stam A, Newburg DS. 1994; Oligosaccharides from human milk block binding and activity of the Escherichia coli heat-stable enterotoxin (STa) in T84 intestinal cells. J Nutr. 124:2358-2364

14.

Daddaoua A, Puerta V, Requena P, Marti´nez-Fe´rez A, Guadix E, de Medina FS, Zarzuelo A, Suárez MD, Boza JJ, Martínez-Augustin O. 2006; Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. Nutr Immun. 136:672-676

15.

DuBois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. 1956; Colorimetric method for determination of sugars and related substances. Anal Chem. 28:350-356

16.

Food and Agriculture Organization (FAO). 2021 FAO stat. Available fromhttps://www.fao.org/faostat/en/#data/QCLAccessed at Nov 19, 2021

17.

Fukuda K, Yamamoto A, Ganzorig K, Khuukhenbaatar J, Senda A, Saito T, Urashima T. 2010; Chemical characterization of the oligosaccharides in Bactrian camel (Camelus bactrianus) milk and colostrum. J Dairy Sci. 93:5572-5587

18.

Ganzorig K, Asakawa T, Sasaki M, Saito T, Suzuki I, Fukuda K, Urashima T. 2018; Identification of sialyl oligosaccharides including an oligosaccharide nucleotide in colostrum of an addax (Addax nasomaculatus) (Subfamily Antelopinae). Anim Sci J. 89:167-175

19.

Gopal PK, Gill HS. 2000; Oligosaccharides and glycoconjugates in bovine milk and colostrum. Br J Nutr. 84(Suppl 1):S69-S74

20.

Huang Z, Li Y, Luo Y, Guo H. 2021; Human milk oligosaccharides 3’-sialyllactose and 6’-sialyllactose protect intestine against necrotizing enterocolitis damage induced by hypoxia. J Funct Foods. 86:104708

21.

Jourdian GW, Dean L, Roseman S. 1971; The sialic acids: XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J Biol Chem. 246:430-435

22.

Kiskini A, Difilippo E. 2013; Oligosaccharides in goat milk: Structure, health effects and isolation. Cell Mol Biol. 59:25-30.

23.

Kunz C, Kuntz S, Rudloff S. 2014; Bioactivity of human milk oligosaccharides. In Food oligosaccharides: Production, analysis and bioactivity. In: Moreno FJ, Sanz ML, editors.John Wiley & Sons. London, UK: p. 1-20

24.

Lane JA, Mariño K, Rudd PM, Carrington SD, Slattery H, Hickey RM. 2012; Methodologies for screening of bacteria–carbohydrate interactions: Anti-adhesive milk oligosaccharides as a case study. J Microbiol Methods. 90:53-59

25.

Lane JA, Mehra RK, Carrington SD, Hickey RM. 2010; The food glycome: A source of protection against pathogen colonization in the gastrointestinal tract. Int J Food Microbiol. 142:1-13

26.

Leong A, Liu Z, Almshawit H, Zisu B, Pillidge C, Rochfort S, Gill H. 2019; Oligosaccharides in goats’ milk-based infant formula and their prebiotic and anti-infection properties. Br J Nutr. 122:441-449

27.

Lu J, Zhang Y, Song B, Zhang S, Pang X, Sari RN, Liu L, Wang J, Lv J. 2020; Comparative analysis of oligosaccharides in Guanzhong and Saanen goat milk by using LC-MS/MS. Carbohydr Polym. 235:115965

28.

Martinez-Ferez A, Guadix A, Guadix EM. 2006a; Recovery of caprine milk oligosaccharides with ceramic membranes. J Membr Sci. 276:23-30

29.

Martinez-Ferez A, Rudloff S, Guadix A, Henkel CA, Pohlentz G, Boza JJ, Guadix EM, Kunz C. 2006b; Goats’ milk as a natural source of lactose-derived oligosaccharides: Isolation by membrane technology. Int Dairy J. 16:173-181

30.

Martín-Ortiz A, Barile D, Salcedo J, Moreno FJ, Clemente A, Ruiz-Matute AI, Sanz ML. 2017; Changes in caprine milk oligosaccharides at different lactation stages analyzed by high performance liquid chromatography coupled to mass spectrometry. J Agric Food Chem. 65:3523-3531

31.

Martín-Ortiz A, Salcedo J, Barile D, Bunyatratchata A, Moreno FJ, Martin-García I, Clemente A, Sanz ML, Ruiz-Matute AI. 2016; Characterization of goat colostrum oligosaccharides by nano-liquid chromatography on chip quadrupole time-of-flight mass spectrometry and hydrophilic interaction liquid chromatography-quadrupole mass spectrometry. J Chromatogr A. 1428:143-153

32.

Martín-Sosa S, Martín MJ, García-Pardo LA, Hueso P. 2003; Sialyloligosaccharides in human and bovine milk and in infant formulas: Variations with the progression of lactation. J Dairy Sci. 86:52-59

33.

Meyrand M, Dallas DC, Caillat H, Bouvier F, Martin P, Barile D. 2013; Comparison of milk oligosaccharides between goats with and without the genetic ability to synthesize αs1-casein. Small Rumin Res. 113:411-420

34.

Nakamura T, Kawase H, Kimura K, Watanabe Y, Ohtani M, Arai I, Urashima T. 2003; Concentrations of sialyloligosaccharides in bovine colostrum and milk during the prepartum and early lactation. J Dairy Sci. 86:1315-1320

35.

Nakamura T, Urashima T, Nakagawa M, Saito T. 1998; Sialyllactose occurs as free lactones in ovine colostrum. Biochim Biophys Acta. 1381:286-292

36.

Newburg DS. 1999; Human milk glycoconjugates that inhibit pathogens. Curr Med Chem. 6:117-127

37.

Newburg DS. 2000; Oligosaccharides in human milk and bacterial colonization. J Pediatr Gastroenterol Nutr. 30(Suppl 2):S8-S17

38.

Newburg DS, Ko JS, Leone S, Nanthakumar NN. 2016; Human milk oligosaccharides and synthetic galactosyloligosaccharides contain 3’-, 4-, and 6’-galactosyllactose and attenuate inflammation in human T84, NCM-460, and H4 cells and intestinal tissue ex vivo. J Nutr. 146:358-367

39.

Newburg DS, Neubauer SH. 1995; Carbohydrates in milks: Analysis, quantities and significance. In Handbook of milk composition. In: Jensen RG, editor.Academic Press. San Diego, CA, USA: p. 273-349

40.

Oliveira DL, Wilbey RA, Grandison AS, Roseiro LB. 2015; Milk oligosaccharides: A review. Int J Dairy Technol. 68:305-321

41.

Perret S, Sabin C, Dumon C, Pokorná M, Gautier C, Galanina O, Ilia S, Bovin N, Nicaise M, Desmadril M, Gilboa-Garber N, Wimmerová M, Mitchell EP, Imberty A. 2005; Structural basis for the interaction between human milk oligosaccharides and the bacterial lectin PA-IIL of Pseudomonas aeruginosa. Biochem J. 389:325-332

42.

Plaza-Díaz J, Fontana L, Gil A. 2018; Human milk oligosaccharides and immune system development. Nutrients. 10:1038

43.

Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. 2003; Campylobacter jejuni binds intestinal H(O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem. 278:14112-14120

44.

Saito T, Itoh T, Adachi S. 1984; Presence of two neutral disaccharides containing N-acetylhexosamine in bovine colostrum as free forms. Biochim Biophys Acta. 801:147-150

45.

Saito T, Itoh T, Adachi S. 1987; Chemical structure of three neutral trisaccharides isolated in free form from bovine colostrum. Carbohydr Res. 165:43-51

46.

Sasaki M, Nakamura T, Hirayama K, Fukuda K, Saito T, Urashima T, Asakuma S. 2016; Characterization of two novel sialyl N-acetyllactosaminyl nucleotides separated from ovine colostrum. Glycoconj J. 33:789-796

47.

Silanikove N, Leitner G, Merin U, Prosser CG. 2010; Recent advances in exploiting goat’s milk: Quality, safety and production aspects. Small Rumin Res. 89:110-124

48.

Sousa YRF, Araújo DFS, Pulido JO, Pintado MME, Martínez-Férez A, Queiroga RCRE. 2019a; Composition and isolation of goat cheese whey oligosaccharides by membrane technology. Int J Biol Macromol. 139:57-62

49.

Sousa YRF, Medeiros LB, Pintado MME, Queiroga RCRE. 2019b; Goat milk oligosaccharides: Composition, analytical methods and bioactive and nutritional properties. Trends Food Sci Technol. 92:152-161

50.

Sundekilde UK, Barile D, Meyrand M, Poulsen NA, Larsen LB, Lebrilla CB, German JB, Bertram HC. 2012; Natural variability in bovine milk oligosaccharides from Danish Jersey and Holstein-Friesian breeds. J Agric Food Chem. 60:6188-6196

51.

Taufik E, Fukuda K, Senda A, Saito T, Williams C, Tilden C, Eisert R, Oftedal O, Urashima T. 2012; Structural characterization of neutral and acidic oligosaccharides in the milks of strepsirrhine primates: Greater galago, aye-aye, Coquerel’s sifaka and mongoose lemur. Glycoconj J. 29:119-134

52.

Taufik E, Ganzorig K, Nansalmaa M, Fukuda R, Fukuda K, Saito T, Urashima T. 2014; Chemical characterisation of saccharides in the milk of a reindeer (Rangifer tarandus tarandus). Int Dairy J. 34:104-108

53.

Urakami H, Saeki M, Watanabe Y, Kawamura R, Nishizawa S, Suzuki Y, Watanabe A, Ajisaka K. 2018; Isolation and assessment of acidic and neutral oligosaccharides from goat milk and bovine colostrum for use as ingredients of infant formulae. Int Dairy J. 83:1-9

54.

Urashima T, Bubb WA, Messer M, Tsuji Y, Taneda Y. 1994; Studies of the neutral trisaccharides of goat (Capra hircus) colostrum and of the one- and two-dimensional 1H and 13C NMR spectra of 6’-N-acetylglucosaminyllactose. Carbohydr Res. 262:173-184

55.

Urashima T, Murata S, Nakamura T. 1997; Structural determination of monosialyl trisaccharides obtained from caprine colostrum. Comp Biochem Physiol B Biochem Mol Biol. 116:431-435

56.

Urashima T, Saito T, Nakamura T, Messer M. 2001; Oligosaccharides of milk and colostrum in non-human mammals. Glycoconj J. 18:357-371

57.

Urashima T, Taufik E. 2010; Oligosaccharides in milk: Their benefits and future utilization. Media Peternakan. 33:189

58.

Urashima T, Taufik E, Fukuda K, Asakuma S. 2013; Recent advances in studies on milk oligosaccharides of cows and other domestic farm animals. Biosci Biotechnol Biochem. 77:455-466

59.

van Leeuwen SS, Te Poele EM, Chatziioannou AC, Benjamins E, Haandrikman A, Dijkhuizen L. 2020; Goat milk oligosaccharides: Their diversity, quantity, and functional properties in comparison to human milk oligosaccharides. J Agric Food Chem. 68:13469-13485

60.

Viverge D, Grimmonprez L, Solere M. 1997; Chemical characterization of sialyl oligosaccharides isolated from goat (Capra hircus) milk. Biochim Biophys Acta. 1336:157-164

61.

Yue H, Han Y, Yin B, Cheng C, Liu L. 2020; Comparison of the antipathogenic effect toward Staphylococcus aureus of N-linked and free oligosaccharides derived from human, bovine, and goat milk. J Food Sci. 85:2329-2339

62.

Zopf D, Roth S. 1996; Oligosaccharide anti-infective agents. Lancet. 347:1017-1021

Call for Special Section


We are pleased to invite you a paper for Food Science of Animal Resources for a special issue “New concept of probiotics for human and animal health”. Both research and review articles are welcome for possible publication in this issue. Both research and review articles are welcome for possible publication in this section. All manuscript will be peer-reviewed before their acceptance for publication.

Edited by Dr. Seok-Seong Kang
- Deadline for manuscript submissions: 30 June 31 July 2022
- We offer 50% reduction of the article processing charge and provide the fast review process (approximately 1 month).

The specific topics of interest for the special issue include:
 • New probiotics and alternative probiotics such as postbiotics
 • Probiotics/postbiotics for human and animal health
 • Probiotics/postbiotics and metabolic disorders
 • Probiotics/postbiotics and gut microbiome balance
 • The next generation of probiotics


I don't want to open this window for a day.